A longitudinal analysis of the economic cost of all phases of TB care in a low incidence setting
Ramsay LC, Brode SK, Rea E, Barrett K, Hernandez A, Iragorri N, Liu K, Macdonald L, Sander B. IJTLD Open. 2025; 2(7):404-411.
Publications
Population-based analysis of the risk of mycobacterial infections associated with immune checkpoint inhibitors
Yan M, Hernandez A, Chan KK, Stanbrook MB, Blanchette PS, Johnston JC, Lee SM, Macdonald L, Richard-Greenblatt M, Marras TK, Brode SK. Clin Infect Dis. 2025: ciae626. Epub 2025 Jan 28.
Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data
Puyat JH, Brode SK, Shulha H, Romanowski K, Menzies D, Benedetti A, Duchen R, Huang A, Fang J, Macdonald L, Marras TK, Rea E, Kwong JC, Campitelli MA, Campbell JR, Schwartzman K, Cook VJ, Johnston JC. Clin Infect Dis. 2024; Nov 20 [Epub ahead of print].
Costs associated with nontuberculous mycobacteria infection, Ontario, Canada, 2001–2012
Ramsay LC, Shing E, Wang J, Marras TK, Kwong JC, Brode SK, Jamieson FB, Sander B. Emerg Infect Dis. 2020; 26(9):2097-107. Epub 2020 Sep 1.
The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease (MAC-PD): a population-based cohort study
Brode SK, Chung H, Campitelli MA, Kwong JC, Sutradhar R, Marchand-Austin A, Winthrop KL, Jamieson FB, Marras TK. Eur Respir J. 2020; 56(3):1901875. Epub 2020 May 13.
Prescribing patterns for treatment of Mycobacterium avium complex and M. xenopi pulmonary disease in Ontario, Canada, 2001–2013
Brode SK, Chung H, Campitelli MA, Kwong JC, Marchand-Austin A, Winthrop KL, Jamieson FB, Marras TK. Emerg Infect Dis. 2019; 25(7):1271-80. Epub 2019 Jul 1.
The risk of mycobacterial infections associated with inhaled corticosteroid use
Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, Jamieson FB, Marras TK. Eur Respir J. 2017; 50(3):1700037. Epub 2017 Sep 21.
Pulmonary nontuberculous mycobacteria-associated deaths, Ontario, Canada, 2001-2013
Marras TK, Campitelli MA, Lu H, Chung H, Brode SK, Marchand-Austin A, Winthrop KL, Gershon AS, Kwong JC, Jamieson FB. Emerg Infect Dis. 2017; 23(3):468-76.
Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease
Marras TK, Campitelli MA, Kwong JC, Lu H, Brode SK, Marchand-Austin A, Gershon AS, Jamieson FB. Eur Respir J. 2016; 48(3):928-31. Epub 2016 Jun 10.
Increased risk of mycobacterial infections associated with anti-rheumatic medications
Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Thorax. 2015; 70(7): 677-82. Epub 2015 Apr 24.